We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
2176
AMC Global Media
AMCX
$488M
$119K ﹤0.01%
3,308
-39,933
-92% -$1.12M
PPLI
2177
People Inc
PPLI
$3B
$119K ﹤0.01%
1,151
-4,217
-79% -$323K
JOE icon
2178
St. Joe Company
JOE
$3.85B
$119K ﹤0.01%
2,798
-20,487
-88% -$652K
LMND icon
2179
Lemonade
LMND
$4.05B
$119K ﹤0.01%
967
-789
-45% -$58.2K
PRA
2180
DELISTED
ProAssurance
PRA
$119K ﹤0.01%
6,677
-183,496
-96% -$2.99M
SSP icon
2181
E.W. Scripps
SSP
$306M
$119K ﹤0.01%
7,794
-54,148
-87% -$666K
UFI icon
2182
UNIFI
UFI
$127M
$119K ﹤0.01%
6,698
-10,950
-62% -$169K
BWIN
2183
Baldwin Insurance Group
BWIN
$2.91B
$119K ﹤0.01%
3,968
-20,849
-84% -$603K
CATC
2184
DELISTED
CAMBRIDGE BANCORP
CATC
$119K ﹤0.01%
1,703
-4,440
-72% -$296K
ALXO icon
2185
ALX Oncology
ALXO
$275M
$118K ﹤0.01%
1,373
-210
-13% -$12.6K
DHS icon
2186
WisdomTree US High Dividend Fund
DHS
$1.58B
$118K ﹤0.01%
1,701
-3,474
-67% -$232K
IMUX icon
2187
Immunic
IMUX
$212M
$118K ﹤0.01%
770
+425
+123% +$76.3K
ESTE
2188
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$118K ﹤0.01%
22,145
-10,944
-33% -$37.9K
HHH icon
2189
Howard Hughes
HHH
$3.92B
$117K ﹤0.01%
1,554
+431
+38% +$28.9K
NTNX icon
2190
Nutanix
NTNX
$17.2B
$117K ﹤0.01%
3,665
+3,508
+2,234% +$95.1K
RWT
2191
Redwood Trust
RWT
$590M
$117K ﹤0.01%
13,254
-138,516
-91% -$1.19M
SMPL icon
2192
Simply Good Foods
SMPL
$954M
$117K ﹤0.01%
3,734
-73,859
-95% -$1.72M
VCSH icon
2193
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$117K ﹤0.01%
1,400
VTOL icon
2194
Bristow Group
VTOL
$1.36B
$117K ﹤0.01%
4,445
-13,191
-75% -$322K
ALTR
2195
DELISTED
Altair Engineering Inc
ALTR
$117K ﹤0.01%
2,019
-32,966
-94% -$1.66M
AYX
2196
DELISTED
Alteryx Inc
AYX
$117K ﹤0.01%
962
-5,766
-86% -$727K
HSKA
2197
DELISTED
Heska Corp
HSKA
$117K ﹤0.01%
806
-5,770
-88% -$718K
CERS icon
2198
Cerus
CERS
$536M
$116K ﹤0.01%
16,685
-123,763
-88% -$812K
IMMR icon
2199
Immersion
IMMR
$244M
$116K ﹤0.01%
10,299
-12,920
-56% -$102K
ITIC
2200
Investors Title Co
ITIC
$535M
$116K ﹤0.01%
752
-737
-49% -$114K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.